Literature DB >> 28682327

Fischer et al. reply.

Kari R Fischer1,2,3,4,5, Nasser K Altorki1,3, Vivek Mittal1,2,3, Dingcheng Gao1,2,3.   

Abstract

Entities:  

Year:  2017        PMID： 28682327      PMCID： PMC6377064          DOI： 10.1038/nature22817

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

Review 1.  EMT: 2016.

Authors:  M Angela Nieto; Ruby Yun-Ju Huang; Rebecca A Jackson; Jean Paul Thiery
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

2.  Collective invasion in breast cancer requires a conserved basal epithelial program.

Authors:  Kevin J Cheung; Edward Gabrielson; Zena Werb; Andrew J Ewald
Journal:  Cell       Date:  2013-12-12       Impact factor: 41.582

3.  Transient SNAIL1 expression is necessary for metastatic competence in breast cancer.

Authors:  Hung D Tran; Krishna Luitel; Michael Kim; Kun Zhang; Gregory D Longmore; David D Tran
Journal:  Cancer Res       Date:  2014-08-27       Impact factor: 12.701

Review 4.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

5.  Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.

Authors:  Kevin J Cheung; Veena Padmanaban; Vanesa Silvestri; Koen Schipper; Joshua D Cohen; Amanda N Fairchild; Michael A Gorin; James E Verdone; Kenneth J Pienta; Joel S Bader; Andrew J Ewald
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

6.  EMT and dissemination precede pancreatic tumor formation.

Authors:  Andrew D Rhim; Emily T Mirek; Nicole M Aiello; Anirban Maitra; Jennifer M Bailey; Florencia McAllister; Maximilian Reichert; Gregory L Beatty; Anil K Rustgi; Robert H Vonderheide; Steven D Leach; Ben Z Stanger
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

7.  Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Authors:  Manav Korpal; Brian J Ell; Francesca M Buffa; Toni Ibrahim; Mario A Blanco; Toni Celià-Terrassa; Laura Mercatali; Zia Khan; Hani Goodarzi; Yuling Hua; Yong Wei; Guohong Hu; Benjamin A Garcia; Jiannis Ragoussis; Dino Amadori; Adrian L Harris; Yibin Kang
Journal:  Nat Med       Date:  2011-08-07       Impact factor: 53.440

8.  Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Authors:  Xiaofeng Zheng; Julienne L Carstens; Jiha Kim; Matthew Scheible; Judith Kaye; Hikaru Sugimoto; Chia-Chin Wu; Valerie S LeBleu; Raghu Kalluri
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

9.  Distinct EMT programs control normal mammary stem cells and tumour-initiating cells.

Authors:  Xin Ye; Wai Leong Tam; Tsukasa Shibue; Yasemin Kaygusuz; Ferenc Reinhardt; Elinor Ng Eaton; Robert A Weinberg
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

10.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962
View more
  12 in total

1.  Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis.

Authors:  Ana Rita Lourenco; Yi Ban; Michael J Crowley; Sharrell B Lee; Divya Ramchandani; Wei Du; Olivier Elemento; Jason T George; Mohit Kumar Jolly; Herbert Levine; Jianting Sheng; Stephen T Wong; Nasser K Altorki; Dingcheng Gao
Journal:  Cancer Res       Date:  2019-11-08       Impact factor: 12.701

2.  EMT in cancer.

Authors:  Thomas Brabletz; Raghu Kalluri; M Angela Nieto; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

Review 3.  EMT, MET, Plasticity, and Tumor Metastasis.

Authors:  Basil Bakir; Anna M Chiarella; Jason R Pitarresi; Anil K Rustgi
Journal:  Trends Cell Biol       Date:  2020-08-13       Impact factor: 20.808

4.  Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors.

Authors:  Kyra Campbell; Fabrizio Rossi; Jamie Adams; Ioanna Pitsidianaki; Francisco M Barriga; Laura Garcia-Gerique; Eduard Batlle; Jordi Casanova; Andreu Casali
Journal:  Nat Commun       Date:  2019-05-24       Impact factor: 14.919

Review 5.  CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs.

Authors:  Andrew Sulaiman; Sarah McGarry; Xianghui Han; Sheng Liu; Lisheng Wang
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

Review 6.  The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis.

Authors:  Chia-Jung Li; Pei-Yi Chu; Giou-Teng Yiang; Meng-Yu Wu
Journal:  Biomolecules       Date:  2019-09-11

7.  Multi-Omics Characterization of the Spontaneous Mesenchymal-Epithelial Transition in the PMC42 Breast Cancer Cell Lines.

Authors:  Sugandha Bhatia; James Monkman; Tony Blick; Pascal Hg Duijf; Shivashankar H Nagaraj; Erik W Thompson
Journal:  J Clin Med       Date:  2019-08-19       Impact factor: 4.241

Review 8.  Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Authors:  Elizabeth D Williams; Dingcheng Gao; Andrew Redfern; Erik W Thompson
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

Review 9.  The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.

Authors:  Monica Fedele; Laura Cerchia; Gennaro Chiappetta
Journal:  Cancers (Basel)       Date:  2017-09-30       Impact factor: 6.639

Review 10.  Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis.

Authors:  Kyra Campbell
Journal:  Curr Opin Cell Biol       Date:  2018-07-11       Impact factor: 8.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.